Navigation Links
Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
Date:1/24/2008

g and complex process and I would like to thank all of the participants in the dialogue that has led to this recommendation by the EMEA, which include European thalidomide groups, patient organizations, the hematology community and the employees of Pharmion who made this happen. We have been and will remain committed to managing Thalidomide with the respect that its history requires."

The Marketing Authorization Application reviewed by the EMEA is based upon a clinical data package comprised of studies of nearly 1400 patients in total, including the Intergroupe Francophone du Myelome (IFM) 99-06 survival study. The three-arm study conducted by IFM demonstrated the superiority of melphalan/prednisone plus Thalidomide (MPT) over standard therapy of melphalan/prednisone (MP) or a combination of chemotherapies (vincristine/adriamycin/dexamethasone (VAD)) followed by melphalan and transplantation (MEL 100) in the treatment of newly diagnosed multiple myeloma patients, aged 65 to 75 who were ineligible for intensive bone marrow transplantation. A total of 447 patients were randomized to one of the three treatment arms. At final analysis, the overall median survival in the MPT arm was 51.6 months, compared to 33.2 and 38.3 months, respectively, for the MP and MEL 100 arms. The hazard ratios were 0.59 and 0.69, respectively. Thalidomide treatment was generally well-tolerated by the majority of patients. The most frequently reported adverse events associated with MPT included neutropenia, somnolence and constipation. The Thalidomide combination was also associated with a 5-10% greater risk of Grade 3 and 4 venous thromboembolism and peripheral neuropathy.

"Our study results demonstrate the profound impact on overall survival that the addition of Thalidomide to the standard of care can provide to patients with untreated multiple myeloma," said Professor Philippe Moreau, Professor of Clinical Hematology at Nantes Faculty of Medicine and Chairman of the Intergroup
'/>"/>

SOURCE Pharmion Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
2. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
3. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
4. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
5. Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial
6. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
7. Hawaii Biotech Receives Allowance to Perform West Nile Vaccine Clinical Trials
8. Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma
9. Antheras A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
10. Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
11. Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)...  Syneron Medical Ltd. (NASDAQ: ELOS ), a leading ... three month period ended June 30, 2015. ... Highlights: , Revenue of $73.5 million, up ... American product sales grew 45% year-over-year. , International sales ... product growth in the EMEA region and 25% product growth ...
(Date:8/4/2015)... 4, 2015  Ironshore Pharmaceuticals & Development, Inc. ... a company specializing in personalized medicine, to participate ... designed to evaluate the safety and efficacy of ... Attention-deficit/hyperactivity disorder (ADHD). This is Restore,s second clinical ... originally partnered with Ironshore in 2014 and continues ...
(Date:8/3/2015)... PHILADELPHIA , Aug. 4, 2015   ... Reuters , the world,s leading provider of intelligent ... of the 2015 CMR Pharmaceutical R&D Factbook ... R&D trends. Despite concerns around declines in R&D, ... with 2014,s $1 trillion milestone and forecasts sales ...
Breaking Medicine Technology:Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 2Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 3Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 4Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 5Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 6Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 7Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 8Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 9Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 10Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 11Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 12Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 13Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 14Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 15Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 16Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 17Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2Pharma Sales to Grow Beyond $1 Trillion 2
... CHENGDU , Sichuan, China , ... TPI ) was invited by Sino American Biopharmaceutical,Association (SABPA) ... at, Irvine, California on April 24th, 2010 ... biotechnology industries, as well as,business opportunities to thrive in ...
... PharmaMar, a biopharmaceutical company owned by Grupo Zeltia (ZEL.MC), presented six ... American Association for Cancer Research,s (AACR) 101st Annual Meeting, held in ... , , ... cancer research, bringing together more than 17,000 attendees each year and covering ...
Cached Medicine Technology:Tianyin to Present at 5th Annual Biomedical Forum by Sino American BioPharmaceutical Association 2Tianyin to Present at 5th Annual Biomedical Forum by Sino American BioPharmaceutical Association 3PharmaMar Presents New Clinical Trials With Three Marine-Based Drugs at the American Association for Cancer Research Convention 2PharmaMar Presents New Clinical Trials With Three Marine-Based Drugs at the American Association for Cancer Research Convention 3
(Date:8/4/2015)... ... August 04, 2015 , ... More than 700 years of marital bliss ... on Friday, July 24th. Chaplains Shawn Kafader and Richard Oas lead the non-denominational ... the ceremony was a reception, with music by the Moonlight Serenade Orchestra and a ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... one of 20 finalists for America’s Favorite Veterinarian. The contest is put on ... a judging committee from 500 nominees. Nominees were evaluated on community involvement, ethical ...
(Date:8/4/2015)... ... August 04, 2015 , ... The Law Offices of Ben C. Martin ... dealing with Inferior Vena Cava Filters (“IVC Filters”). , As lead IVC filter lawyer ... IVC Filter clients under In re Cook Medical, Inc., IVC Filters Marketing, Sales Practices ...
(Date:8/4/2015)... ... August 04, 2015 , ... In the most recent ... & Johnson report that a new location for pretrial proceedings is under consideration, ... and cancer warning information at their website, the Talcum Powder Cancer Lawsuit Center. ...
(Date:8/4/2015)... ... 04, 2015 , ... Continuing Education Company (CEC) ... interaction simulation session entitled "NOACS: What the Evidence Shows in Managing AFib, ... Inc. and EDUmotion US LLC. , This special activity was recently presented during ...
Breaking Medicine News(10 mins):Health News:Couples Renew Vows at Friendship Village of Schaumburg 2Health News:Dr. Gary Richter, Oakland Holistic Veterinarian, Among 20 Finalists for America’s Favorite Veterinarian 2Health News:Dr. Gary Richter, Oakland Holistic Veterinarian, Among 20 Finalists for America’s Favorite Veterinarian 3Health News:Law Offices of Ben C. Martin in Dallas Files New IVC Filter Complications Lawsuits and Pursues Settlements 2Health News:Law Offices of Ben C. Martin in Dallas Files New IVC Filter Complications Lawsuits and Pursues Settlements 3Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 2Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 3Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 4Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 2Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 3
... MOUNTAIN VIEW, Calif., March 2 MAP Pharmaceuticals, Inc. (Nasdaq: ... fourth quarter and year ended December 31, 2008.The net loss ... million compared with $14.9 million during the same period in ... 2008 was $72.9 million compared with $40.1 million for the ...
... Ala., March 2 HealthSouth Corporation (NYSE: ... Barclays Capital Global Healthcare Conference on March 10-11, 2009, ... Fla.HealthSouth President and Chief Executive Officer Jay Grinney and ... will be speaking on Tuesday, March 10, at 9:30 ...
... Mild asthma symptoms fall after just a week away, study ... a week away from urban air pollution, children with mild ... health. , A study in the March issue of ... group of school-age children left the city for a rural ...
... WLP ),announced today that senior management is scheduled to ... Raymond James 30th Annual Institutional Investors Conference on March,9, 2009, ... -- Barclays Capital 2009 Global Healthcare Conference ... All interested parties are invited to listen to ...
... NORTH HOLLYWOOD, Calif., March 2 IPC The Hospitalist Company, Inc. ... practice, today announced financial results for the fourth quarter and full ... , Net ... same-market area net revenue growth of 19% , ...
... Second Harvest Heartland report uncovers staggering shortfall in meals ... of food to start filling the gapSAINT PAUL, Minn., ... Harvest Heartland, the Upper Midwest,s leading voice on hunger ... million meals every year--the equivalent of those in need ...
Cached Medicine News:Health News:MAP Pharmaceuticals Reports 2008 Fourth Quarter and Year End Financial Results 2Health News:MAP Pharmaceuticals Reports 2008 Fourth Quarter and Year End Financial Results 3Health News:MAP Pharmaceuticals Reports 2008 Fourth Quarter and Year End Financial Results 4Health News:MAP Pharmaceuticals Reports 2008 Fourth Quarter and Year End Financial Results 5Health News:MAP Pharmaceuticals Reports 2008 Fourth Quarter and Year End Financial Results 6Health News:MAP Pharmaceuticals Reports 2008 Fourth Quarter and Year End Financial Results 7Health News:City Kids Find the Breathin' Is Easier Elsewhere 2Health News:City Kids Find the Breathin' Is Easier Elsewhere 3Health News:WellPoint Announces Appearances at Upcoming Conferences 2Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 2Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 3Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 4Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 5Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 6Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 7Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 8Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 9Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 10Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 11Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 12Health News:Missing: 125 Million Meals for Low-Income Minnesotans 2Health News:Missing: 125 Million Meals for Low-Income Minnesotans 3Health News:Missing: 125 Million Meals for Low-Income Minnesotans 4
Designed to safely and easily removing a cataract nucleus, round serrated handle, dull finish....
Round handle dull finish. For right handed surgeon....
Specially designed wider jaws to help split soft nucleus, cross action, round handle, maximum opening 2.8 mm....
Specially designed wider jaws to help split soft nucleus, cross action, round handle, maximum opening 2.8 mm....
Medicine Products: